Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 915

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 5
Chunk 915
---

the offering, before deducting the placement agent’s fees and other offering expenses, were approximately $4.7 million. Net
proceeds, of the offering, after deducting the placement agent fees and expenses and other offering expenses payable by us, were are approximately
$3.5 million. In June 2024, and holders of Class A and Class B warrants exercised 37,500 shares and 360,000 shares,
respectively, for additional proceeds of $1,844,400.

The shares of Common
Stock, the Class A and Class B warrants, the pre-funded warrants and the Placement Agent Warrants described above and the underlying shares
of Common Stock were offered pursuant to a Registration Statement on Form S-1, as amended (File No. 333-278188) (the “Registration
Statement”), which was declared effective by the Securities and Exchange Commission (the “SEC”) on May 15, 2024

     F-17 

RSU Grants to Non-Employee Directors 

In
April 2024, the Compensation Committee of the Board, or Compensation Committee, approved, pursuant to the terms of the Company’s
Amended and Restated Non-Employee Director Compensation Policy, or the Director Compensation Policy, the grant of the annual RSUs under
the Director Compensation Policy to each of the three non-employee directors of the Company then serving on the Board of Directors of
the Company, or Board. The Director Compensation Policy provides for a grant of stock options or $50,000 worth of RSUs at the beginning
of each fiscal year for current non-employee directors then serving on the Board, and for a grant of stock options or $75,000 worth of
RSUs for a newly elected non-employee director, with each RSU priced at the average for the closing prices for the five days preceding
and including the date of grant, or $12.16 per share for the April 2024 RSU grants. As a result, in April 2024 the four eligible directors
were each granted an RSU in the amount of 4,112 shares under the 2020 Plan. The RSUs are subject to vesting in four equal installments,
with 25% of the restricted stock units vesting on each of June 30, 2024, September 30, 2024, December 31, 2024, and March 31, 2025, subject
in each case